Submit a complete response to the CTI-1601 clinical hold
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Aug 2022
- Due
- 30 Sep 2022
- Delivered
- August 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022”
What we found
Evidence strength A What the grades mean
The company submitted a complete response to the FDA regarding the CTI-1601 clinical hold in August 2022, which falls within the third quarter of 2022.
-
A Larimar Therapeutics, Inc. 10-Q filed 2023-08-10
“In August 2022, the Company submitted a complete response to the clinical hold, following a Type C Meeting with the FDA” ✓ confirmed on the page
Market reaction: the shares moved +5.2% against the S&P 500 over the three sessions around the disclosure (9 Aug 2023 to 14 Aug 2023). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- Complete response to CTI-1601 clinical hold
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Larimar Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-LRMR-002936 · Corrections policy